Selected research
Industry Research
Gastro Esophageal Reflux Disease (GERD) Drug Industry Research Report 2026
Market perspective
The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gastro Esophageal Reflux Disease (GERD) Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gastro Esophageal Reflux Disease (GERD) Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug include Addex Therapeutics, Aros Pharma, AstraZeneca, Plc., Medtronic, Takeda Pharmaceutical Company Limited, The Kroger Co., GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gastro Esophageal Reflux Disease (GERD) Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gastro Esophageal Reflux Disease (GERD) Drug Market by Company
Addex Therapeutics
Aros Pharma
AstraZeneca, Plc.
Medtronic
Takeda Pharmaceutical Company Limited
The Kroger Co.
GlaxoSmithKline
Pfizer
Merck
Novartis AG
Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids
Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
Clinic
Hospital
Medical Center
Others
Gastro Esophageal Reflux Disease (GERD) Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastro Esophageal Reflux Disease (GERD) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gastro Esophageal Reflux Disease (GERD) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastro Esophageal Reflux Disease (GERD) Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gastro Esophageal Reflux Disease (GERD) Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gastro Esophageal Reflux Disease (GERD) Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gastro Esophageal Reflux Disease (GERD) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- H2 Receptor Antagonist
- Proton Pump Inhibitor (PPi)
- Antacids
Applications
- Clinic
- Hospital
- Medical Center
- Others
Companies covered
- Addex Therapeutics
- Aros Pharma
- AstraZeneca, Plc.
- Medtronic
- Takeda Pharmaceutical Company Limited
- The Kroger Co.
- GlaxoSmithKline
- Pfizer
- Merck
- Novartis AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (2021-2032)
- 2.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2021-2032)
- 2.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Average Price (2021-2032)
- 2.3 Gastro Esophageal Reflux Disease (GERD) Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 H2 Receptor Antagonist
- 2.3.3 Proton Pump Inhibitor (PPi)
- 2.3.4 Antacids
- 2.4 Gastro Esophageal Reflux Disease (GERD) Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Medical Center
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Product Type & Application
- 3.8 Global Manufacturers of Gastro Esophageal Reflux Disease (GERD) Drug, Established Date
- 3.9 Global Gastro Esophageal Reflux Disease (GERD) Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Addex Therapeutics
- 4.1.1 Addex Therapeutics Company Information
- 4.1.2 Addex Therapeutics Business Overview
- 4.1.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.1.5 Addex Therapeutics Recent Developments
- 4.2 Aros Pharma
- 4.2.1 Aros Pharma Company Information
- 4.2.2 Aros Pharma Business Overview
- 4.2.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.2.5 Aros Pharma Recent Developments
- 4.3 AstraZeneca, Plc.
- 4.3.1 AstraZeneca, Plc. Company Information
- 4.3.2 AstraZeneca, Plc. Business Overview
- 4.3.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.3.5 AstraZeneca, Plc. Recent Developments
- 4.4 Medtronic
- 4.4.1 Medtronic Company Information
- 4.4.2 Medtronic Business Overview
- 4.4.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.4.5 Medtronic Recent Developments
- 4.5 Takeda Pharmaceutical Company Limited
- 4.5.1 Takeda Pharmaceutical Company Limited Company Information
- 4.5.2 Takeda Pharmaceutical Company Limited Business Overview
- 4.5.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.5.5 Takeda Pharmaceutical Company Limited Recent Developments
- 4.6 The Kroger Co.
- 4.6.1 The Kroger Co. Company Information
- 4.6.2 The Kroger Co. Business Overview
- 4.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.6.5 The Kroger Co. Recent Developments
- 4.7 GlaxoSmithKline
- 4.7.1 GlaxoSmithKline Company Information
- 4.7.2 GlaxoSmithKline Business Overview
- 4.7.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.7.5 GlaxoSmithKline Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Merck
- 4.9.1 Merck Company Information
- 4.9.2 Merck Business Overview
- 4.9.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.9.5 Merck Recent Developments
- 4.10 Novartis AG
- 4.10.1 Novartis AG Company Information
- 4.10.2 Novartis AG Business Overview
- 4.10.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
- 4.10.5 Novartis AG Recent Developments
5 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Scenario by Region
- 5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021-2032
- 5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2021-2026
- 5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region: 2027-2032
- 5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2021-2032
- 5.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2021-2026
- 5.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region: 2027-2032
- 5.4 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
- 5.4.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
- 5.4.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
- 5.5.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
- 5.5.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
- 5.7.1 South America Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
- 5.7.3 South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032)
- 6.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2021-2032)
- 6.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032)
- 7.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2021-2032)
- 7.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gastro Esophageal Reflux Disease (GERD) Drug Value Chain Analysis
- 8.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gastro Esophageal Reflux Disease (GERD) Drug Production Mode & Process
- 8.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors
- 8.2.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers
9 Global Gastro Esophageal Reflux Disease (GERD) Drug Analyzing Market Dynamics
- 9.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
- 9.2 Gastro Esophageal Reflux Disease (GERD) Drug Industry Drivers
- 9.3 Gastro Esophageal Reflux Disease (GERD) Drug Industry Opportunities and Challenges
- 9.4 Gastro Esophageal Reflux Disease (GERD) Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst